EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Concomitant use of medical cannabis and drugs associated with risks of interaction in older patients: a longitudinal cohort study

Zoumana Cheick Bérété iD, Arvis Abraham Sebgo, Dean T Eurich iD, Cerina Dubois iD, Jason R Dyck iD, John G Hanlon, Arsene Zongo iD

Age and Ageing · 2025

DOI: 10.1093/ageing/afaf359 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Age and Ageing, 2025. Verfasst von Zoumana Cheick Bérété und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Université Laval, Québec City, Quebec, Canada. Hauptthemen laut MEDLINE: Medical Marijuana, Warfarin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cannabinoids interact with multiple drugs, with some interactions having significant clinical effects.

Objectives

This study aimed to evaluate amongst older people (i) the trends in the concomitant medical use of cannabis and drugs associated with a risk of significant clinical interaction with cannabinoids (DARSCIC), including those with a narrow therapeutic index (drugs with a narrow therapeutic index; DNTI) such as warfarin, and (ii) the risk of bleeding, drug-related intoxication, thyrotoxicosis and major cardiovascular events.

Methods

For objective 1, we conducted an interrupted time series study amongst 12 599 seniors who received an authorised cannabis prescription in Ontario from 2014–2019. Using clinical and medico-administrative data, dispensations of DARSCIC were assessed pre-post cannabis prescription. For objective 2, longitudinal cohort studies were conducted in patients concomitantly exposed to cannabis and warfarin (bleeding) or to DNTI (intoxication) versus controls.

Results

For objective 1, the trends of DARSCIC/DNTI dispensations were similar in the year before and after cannabis prescription. For objective 2, amongst 378 patients exposed to cannabis and warfarin, the risk of bleeding was 1.19, 95%CI (0.71–1.98), compared to 1646 controls. The risk of drug-related intoxication was 2.61, 95%CI (1.42–4.79) amongst 3926 patients exposed to cannabis and DNTI compared to 12 223 controls. Patients exposed to cannabis and levothyroxine (n = 2499) had a significantly higher risk of heart failure but not thyrotoxicosis, acute coronary syndrome or stroke.

Conclusion

These findings indicate that prescribing practices for cannabis may not adequately consider the implications of DARSCIC/DNTI. Enhancing prescriber awareness of these interactions could mitigate the risk of adverse effects such as drug-related intoxication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medical MarijuanaWarfarinHumansMaleFemaleAgedLongitudinal StudiesDrug InteractionsAged, 80 and overHemorrhageOntarioRisk FactorsAnticoagulantsRisk AssessmentInterrupted Time Series AnalysisAge Factors

Stichwörter der Autor:innen

bleedingcannabinoidsdrug interactionintoxicationmedical cannabisolder patientstime series analysis

Substanzen

Medical MarijuanaWarfarinAnticoagulants

Autor:innen und Institutionen

  • Faculty of Pharmacy, Université Laval, Québec City, Quebec, Canada.
  • Population Health and Optimal Health Practices Research Axis, Centre Hospitalier Universitaire de Québec-Université Laval Research Centre, Québec City, Quebec, Canada.
  • School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
  • Department of Mental Health, Johns Hopkins University, Baltimore, Maryland, USA.
  • Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • St. Michael's Hospital Department of Anesthesia, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Zoumana Cheick Bérété, Dean T Eurich, Cerina Dubois, Jason R Dyck, Arsene Zongo

Förderung

  • Canadian Institutes of Health Research Project

Zitieren

APA

Bérété, Z. C., Sebgo, A. A., Eurich, D. T., Dubois, C., Dyck, J. R., Hanlon, J. G., & Zongo, A. (2025). Concomitant use of medical cannabis and drugs associated with risks of interaction in older patients: a longitudinal cohort study. Age and Ageing. https://doi.org/10.1093/ageing/afaf359

Vancouver

Bérété ZC, Sebgo AA, Eurich DT, Dubois C, Dyck JR, Hanlon JG, et al. Concomitant use of medical cannabis and drugs associated with risks of interaction in older patients: a longitudinal cohort study. Age and Ageing. 2025. doi:10.1093/ageing/afaf359

BibTeX
@article{Brt2025,
  author = {Bérété, Zoumana Cheick and Sebgo, Arvis Abraham and Eurich, Dean T and Dubois, Cerina and Dyck, Jason R and Hanlon, John G and Zongo, Arsene},
  title = {Concomitant use of medical cannabis and drugs associated with risks of interaction in older patients: a longitudinal cohort study},
  journal = {Age and Ageing},
  year = {2025},
  doi = {10.1093/ageing/afaf359}
}
Kostenlos starten →